Variable | 0 or 1, 2 metastatic LNs (n = 187) |  ≥ 3 metastatic LNs (n = 56) | Odds Ratio | 95% CI | P-value | |
---|---|---|---|---|---|---|
Age | ||||||
 < 60 | 121(64.7%) | 34(60.7%) | Reference |  |  |  |
 ≥ 60 | 66(35.3%) | 22(39.3%) | 1.186 | 0.642–2.193 | 0.586 | |
Location | ||||||
 UIQ | 31(16.6%) | 8(14.3%) | Reference |  |  | |
 LIQ | 13(7.0%) | 3(5.4%) | 0.812 | 0.341–1.934 | 0.638 | |
 LOQ | 36(19.3%) | 11(19.6%) | 0.726 | 0.195–2.701 | 0.633 | |
 UOQ | 107(57.2%) | 34(60.7%) | 0.962 | 0.442–2.093 | 0.921 | |
Orientation | ||||||
 Parallel | 137(73.3%) | 37(66.1%) | Reference |  |  | |
 Non-parallel | 50(26.7%) | 19(33.9%) | 1.407 | 0.741–2.671 | 0.296 | |
Shape | ||||||
 Regular | 19(10.2%) | 8(14.3%) | Reference |  |  | |
 Irregular | 168(89.8%) | 48(85.7%) | 0.679 | 0.280–1.646 | 0.391 | |
Margin | ||||||
 Circumscribed | 35(18.7%) | 6(10.7%) | Reference |  |  | |
 Non-circumscribed | 152(81.3%) | 50(89.3%) | 1.919 | 0.762–4.830 | 0.166 | |
Calcification | ||||||
 No | 83(44.4%) | 21(37.5%) | Reference |  |  | |
 Yes | 104(55.6%) | 35(62.5%) | 1.330 | 0.720–2.456 | 0.362 | |
Attenuation | ||||||
 No | 128(68.4%) | 31(55.4%) | Reference |  |  | |
 Yes | 59(31.6%) | 25(44.6%) | 1.750 | 0.950–3.222 | 0.073 | |
ER | ||||||
 Negative | 69(36.9%) | 20(35.7%) | Reference |  |  | |
 1 +  | 23(12.3%) | 8(14.3%) | 0.870 | 0.438–1.727 | 0.690 | |
 2 +  | 26(13.9%) | 5(8.9%) | 1.043 | 0.411–2.652 | 0.929 | |
 3 +  | 69(36.9%) | 23(41.1%) | 0.577 | 0.198–1.677 | 0.312 | |
PR | ||||||
 Negative | 81(43.3%) | 28(50.0%) | Reference |  |  | |
 1 +  | 30(16.0%) | 10(17.9%) | 1.267 | 0.587–2.736 | 0.546 | |
 2 +  | 32(17.1%) | 6(10.7%) | 1.222 | 0.468–3.189 | 0.682 | |
 3 +  | 44(23.5%) | 12(21.4%) | 0.688 | 0.233–2.026 | 0.497 | |
Her-2 | ||||||
 Negative | 150(80.2%) | 45(80.4%) | Reference |  |  | |
 Positive | 37(19.8%) | 11(19.6%) | 0.991 | 0.468–2.100 | 0.981 | |
P53 | ||||||
 Negative | 81(43.3%) | 28(50.0%) | Reference |  |  | |
 Positive | 87(46.5%) | 26(46.4%) | 0.352 | 0.077–1.613 | 0.179 | |
 Unknow | 19(10.2%) | 2(3.6%) | 1.157 | 0.626–2.137 | 0.642 | |
Ki-67 | ||||||
  < 14 | 31(16.6%) | 3(5.4%) | Reference |  |  | |
  ≥ 14 | 151(80.7%) | 53(94.6%) | 0.276 | 0.081–0.939 | 0.039* | |
 Unknow | 5(2.7%) | 0(0.0%) |  |  |  | |
Tumor size | ||||||
 T1 | 102(54.5%) | 17(30.4%) | Reference |  |  | |
 T2 | 85(45.5%) | 39(69.6%) | 2.753 | 1.454–5.212 | 0.002* | |
Histological grade | ||||||
 I | 16(8.6%) | 2(3.6%) | Reference |  |  | |
 II | 84(44.9%) | 33(58.9%) | 3.143 | 0.685–14.429 | 0.141 | |
 III | 83(44.4%) | 21(37.5%) | 2.024 | 0.431–9.498 | 0.371 | |
Unknow | 4(2.1%) | 0(0.0%) | Â | Â | Â | Â |